The latest additions to our product lines of cyclic dinucleotides, nucleoside-5'-O-monophosphates and nucleoside-5'-O-triphosphates are:
For a list of all new products please click here.
Biolog Life Science Institute has taken all possible preventative measures to maintain internal processes and prevent further spread of COVID-19. Incoming orders are processed quickly and reliably as usual, and the work on custom syntheses and projects continues. We are available for you during our normal office hours.
We ask our customers, partners and suppliers to inform us as early as possible of any changes that could affect the joint business.
Please contact us with any questions or concerns..
We have expanded our new product line of cyclic oligonucleotides by three new compounds:- c-triGMP - Cat. No. C 367
We would like to thank all our customers, partners, and friends for the good and pleasant cooperation in 2019.
The whole Biolog Team wishes you a healthy and successful New Year!
Wir möchten uns bei allen Kunden, Geschäftspartnern und Freunden für die gute und angenehme Zusammenarbeit im Jahr 2019 bedanken.
Das gesamte Biolog Team wünscht Ihnen ein gesundes und erfolgreiches Neues Jahr!
Biolog is one of the sponsors of the "Nanodomains in cyclic nucleotide signalling: from mechanisms to therapeutic approaches" meeting which will be held at the Imperial College London, UK, September 16-18, 2019.
This meeting gathers renowned experts who will highlight recent advances in understanding the molecular mechanisms underlying cAMP signalling in nano-scale compartments and how such local signalling regulates key cellular and physiological processes in the cardiovascular system. A further focus will be the relevance of cAMP signalling compartments as pharmacological targets for the treatment of cardiovascular diseases. Cutting-edge methodology such as the use of various high-resolution imaging techniques and advanced biosensors, animal models, and the current state of drug development, will be discussed.
For further information please follow the link to the meeting's website.
We are pleased to announce an important change at Biolog:
The operative business of BIOLOG Life Science Institute Forschungslabor und Biochemica-Vertrieb GmbH has been transferred to the newly founded Biolog Life Science Institute GmbH & Co. KG. The founder and General Manager of BIOLOG, Dr. Hans-Gottfried Genieser, is retiring after almost thirty years of business activity and will hand over the management to his long-time employees Andrea Intemann and Dr. Frank Schwede. An official information from the new management is available for download.
The Biolog team will continue to be available to you as a qualified and reliable business partner at the known telephone numbers and e-mail addresses.
We look forward to the continued successful cooperation with all customers and partners.
Wir freuen uns, Ihnen eine wichtige Änderung bei Biolog mitteilen zu können:
Im Zuge der Altersnachfolge wurde das operative Geschäft der BIOLOG Life Science Institute Forschungslabor und Biochemica-Vertrieb GmbH auf die neu gegründete Biolog Life Science Institute GmbH & Co. KG ausgegliedert. Der Firmengründer und bisherige Geschäftsführer, Herr Dr. Hans-Gottfried Genieser, begibt sich damit nach fast dreißigjähriger Geschäftstätigkeit in den Ruhestand und übergibt die Geschäftsführung an seine langjährigen Mitarbeiter Andrea Intemann und Dr. Frank Schwede. Eine offizielle Mitteilung der neuen Geschäftsführung kann hier eingesehen werden.
Das Biolog Team steht Ihnen auch weiterhin als qualifizierter und zuverlässiger Geschäftspartner unter den bekannten Rufnummern und E-Mail-Adressen zur Verfügung.
Wir freuen uns auf die weiterhin erfolgreiche Zusammenarbeit mit all unseren Kunden und Partnern.
We have added four new polymer-linked dimeric (PLD) cGMP analogues to our product portfolio which contain two cGMP moieties linked by polymer chains of different lengths:
These membrane-permeant cGMP dimers exhibit enhanced PKG activation properties by addressing two binding sites simultaneously with a single molecule.
8-(3-Butynylthio)guanosine-3',5'-cyclic monophosphate (8-Bu(3-yne)T-cGMP, Cat. No. B 185) can be used for copper-catalyzed azide-alkyne cycloaddition (CuAAC) "click chemistry" reactions with azide-containing molecules.
8-Fluo-AET-c-diAMP • Cat. No. F 014
Latest additions to our product catalogue are
1) c-triAMP (cyclic triadenylate or c-A3) • Cat. No. C 362
Reference: Kazlauskiene et al., Science, 357, 605-609 (2017): "A Cyclic Oligonucleotide Signaling Pathway in Type III CRISPR-Cas Systems"
2) c-(ApUp) (cUMP-AMP or cUA) • Cat. No. C 357
Reference: Whiteley et al., Nature, 567, 194-199 (2019): "Bacterial cGAS-like Enzymes Synthesize Diverse Nucleotide Signals"
Following nucleoside-5'-O-triphosphates are now available as well:
We have added eight novel cyclic dinucleotides to our continuously expanding product line:
We have added isotope labelled [13C20,15N10]-c-diGMP (Cat. No. C 183) to our continuously expanding product line of cyclic dinucleotides.
[13C20,15N10]-c-diGMP is useful as an internal standard for the detection and quantification of the bacterial signalling nucleotide c-diGMP in bacterial extract samples by LC-MS/MS analysis.
For further information on the [13C20,15N10]-c-diGMP please view the corresponding product detail page.
BIOLOG sponsors the upcoming annual Conference 2019 of the Association for General and Applied Microbiology (VAAM 2019) which will take place in Mainz, Germany, March 17-20, 2019, and the bi-annual FASEB Science Research Conference on NAD+ Metabolism and Signaling to be held in Dublin, Ireland, June 23-28, 2019.
We are pleased to announce a significant price reduction for our product Rp,Rp-2'3'-c-diAMPSS (syn. c[A(2',5')pS[Rp]-A(3',5')pS[Rp]], Cat. No. C 224). Please follow the link to the product detail page for further information.
Rp,Rp-2'3'-c-diAMPSS is a synthetic cyclic dinucleotide with improved stability against degradation by phosphodiesterases and enhanced binding affinity to STING. The related structure c[A(2',5')pS[Sp]-A(3',5')pS[Rp]], Cat. No. C 223 is also available.
Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers involved in the Type III CRISPR-Cas-associated detection and degradation of invasive genetic elements in many prokaryotes. References: Kazlauskiene et al., Science, 357, 605 - 609 (2017); Niewoehner et al., Nature, 548, 543 - 548 (2017).
"Future Products" list structures which are nearly ready for commercialisation. The list will be permanently updated and contains already > 80 items at the moment.
pppG(2',5')pA is considered to be the linear catalytic intermediate in the enzymatic production of 2',3' - cGAMP (aka c[G(2',5')pA(3',5')p], BIOLOG Cat. No. C 161) by the mammalian innate immune DNA sensor cGAMP synthase (cGAS). According to Hall e t al. (2017) human stimulator of interferon genes STING 155 - 341 does not bind pppG(2',5')pA at concentrations of up to 50 μM.
In pppApG a 5'-ATP unit is connected with a 5'-GMP unit via a 3' → 5' linkage to form a linear dinucleotide. pppApG is a potential endogenous metabolite of the metazoan second messenger 2',3'-cGAMP (c[G(2',5')pA(3',5')p], Cat. No. C 161) and/or of the bacterial signalling nucleotide 3'3'-cGAMP (c-(ApGp), Cat. No. C 117). Kranzusch et al. (2014) reported pppApG to be the linear dinucleotide intermediate in the enzymatic production of 3',3'-cGAMP by the Vibrio cholerae pathogenicity factor DncV. References: Kranzusch, P.J. et al., Cell, 158, 1011 - 1021 (2014); Deng, T. et al., J. Virol., 80, 2337 - 2348 (2006).
With Rp-2'-F-dATP-α-S (Cat. No. D 220) and Sp-2'-F-dATP-a-S (Cat. No. D 219) the sulfur-modified analogues of 2'-deoxy-2'-fluoro-ATP (Cat. No. D 074), which are considered to be metabolically more stable, have been added to our product list. In addition, c[3'-[sCya7]-AHC-G(2',5')pA(3',5')p], (Cat. No. C 240), a new NIR fluorescent 2',3'-cGAMP analogue has joined the cyclic dinucleotide tools set.
8-Br-2',3'-cAMP (Cat. No. B 280) is now available from Biolog. This compound is considered to be a membane-permeable analogue of 2',3'-cAMP (Cat. No. A 307) and was recently used by Kosmacz et al. (2018) to study the role of 2',3'-cAMP in the formation of stress granules in Arabidopsis thaliana (Reference: Kosmacz et al., Plant Physiol., 177, 411 - 421 (2018): "Interaction of 2',3'-cAMP with Rbp47b Plays a Role in Stress Granule Formation").
Biolog now offers the endogenous Transient Receptor Potential Melastatin 2 (TRPM2) channel superagonist and potential novel second messenger 2'-deoxy-ADPR (Reference: Fliegert et al., Nat. Chem. Biol., 13, 1036 - 1044 (2017): "2'-Deoxyadenosine 5'-diphosphoribose is an Endogenous TRPM2 Superagonist").
We have added three new products to our product line of NAD and ADPR analogues:
Our product DEACM-caged cAMP (Cat. No. D 042) which was temporarily out of stock, is available again. DEACM-caged cAMP is a caged precursor of the second messenger cAMP and releases both cAMP and a fluorescent coumarin analogue upon irradiation.
Biolog is pleased to be one of the sponsors of the upcoming 70th Annual Meeting of the German Society for Hygiene and Microbiology e. V. (DGHM, February 19-21, 2018, Bochum, Germany, www.dghm-kongress.de) and of the 3rd German Pharm-Tox Summit (DGPT, February 26-March 1, 2018, Göttingen, Germany, www.gpts-kongress.de).
Biolog's Quality Management System certification has been upgraded to the new ISO 9001:2015 standard. Please click here to download a PDF of our updated certificate.
The newly discovered bacterial second messenger c-hexaAMP (syn.: cyclic hexaadenylate / c-A6 / cA6) is now available from Biolog.
c-hexaAMP was recently reported by Niewoehner et al. (2017) and Kazlauskiene et al. (2017) to be a signalling molecule in prokaryotes, involved in the Type III CRISPR-Cas-associated detection and degradation of invasive genetic elements.
We have added a number of new NAD+ analogues, mostly modified at the 8-position of the adenine ring, to our product catalogue. Many of these structures are described in a collaborative paper recently published in Science: Gibson et al., Science, 353, 45 - 50 (2016): "Chemical Genetic Discovery of PARP Targets Reveals a Role for PARP-1 in Transcription Elongation".
Biolog is one of the sponsors of the upcoming 8th International Conference on cGMP - cGMP: Generators, Effectors and Therapeutic Implications. The conference will take place June 23-25, 2017 in Bamberg, Germany.
Visit the meeting website at www.cyclicgmp.net for further information on this event.
Biolog sponsors Microbiology and Infection 2017, the 5th Joint Conference of the DGHM (German Society for Hygiene and Microbiology) & VAAM (Association for General and Applied Microbiology), which will be held March 5-8, 2017 in Würzburg, Germany.
Visit the meeting website at www.microbiology-infection.de for further information on this event.
Latest additions to our product line of cyclic dinucleotides are:
We have added three new products to our broad product line of cyclic nucleotides:
Biolog sponsors the 20th Joint Meeting of the Signal Transduction Society (STS) "Signal Transduction – Receptors, Mediators and Genes" which will be held November 9-11, 2016 in Weimar/Germany. Visit the homepage of the Signal Transduction Society at https://sigtrans.de/index.html.
Three new linear dinucleotides have become available from Biolog:
Biolog sponsors the 5th International Meeting on Anchored cAMP Signaling Pathways which will be held October 6-9, 2016 in Zermatt, Switzerland.
Visit the meeting website at https://wp.unil.ch/akap2016/ for further information on this important event.
We are happy to introduce the new www.biolog.de to you. Our website has been completely revised to offer a fresh look, an extended search function for our products, and an improved online shop system.
If you are a registered user of www.biolog.de, please note that for the purpose of data protection, your address details and login information have not been transferred to the new website. We would therefore like to ask you to create a new online account.
Biolog sponsors the upcoming 22nd International Round Table on Nucleosides, Nucleotides and Nucleic Acids (XXII IRT) (Paris/France, July 18 - 22, 2016, www.paris-irt2016.org).
Biolog sponsors the upcoming German Pharm-Tox Summit 2016 (DGPT) (Berlin/Germany, February 29 - March 3, 2016) and the Annual Conference of the Association for General and Applied Microbiology (VAAM) (Jena/Germany, March 13 - 16, 2016).
The cyclic dinucleotide 2'2'-cGAMP (c[A(2',5')pG(2',5')p], Cat. No. C 210) is now available from Biolog.
Similar to the metazoan second messenger 2'3'-cGAMP (Cat. No. C 161), 2'2'-cGAMP binds the signalling protein STING and subsequently induces type I interferons.
Latest additions to our product line of c-diAMP and c-diGMP-related cyclic dinucleotides:
We have updated the citation lists for our products 2'3'-cGAMP (Cat. No. C 161) and biotinylated 2'3'-cGAMP (Cat. No. C 176) with a study recently published in Science:
Bridgeman, A.; Maelfait, J.; Davenne, T.; Partridge, T.; Peng, Y.; Mayer, A.; Dong, T.; Kaever, V.; Borrow, P.; Rehwinkel, J., Science, 349, 1228 - 1232 (2015): "Viruses Transfer the Antiviral Second Messenger cGAMP Between Cells" - Link to PubMed
Biolog now offers a set containing 0.1 µmol each of c[G(2',5')pS-A(3',5')pS], isomer 1 and c[G(2',5')pS-A(3',5')pS], isomer 2 which are isomeric di-thiophosphate analogues of the metazoan cyclic dinucleotide second messenger c[G(2',5')pA(3',5')p] (aka 2'3'-cGAMP, Cat. No. C 161). Please visit the product detail page for further information on the set.
We are pleased to announce a significant price reduction for our products pApA (Cat. No. P 033) and pGpG (Cat. No. P 023). These products are now sold in 1 µmol vials instead of 0.1 µmol vials at unchanged prices. Please visit the product detail pages for pApA and pGpG for further information.
Together with academic collaborators, Biolog has developed new EPAC agonists that discriminate between the isoforms EPAC1 and EPAC2. Two of the cyclic AMP-based structures described are now exclusively available from Biolog:
Reference: Schwede, F. et al., PLoS Biol., 13(1):e1002038 (2015): "Structure-Guided Design of Selective Epac1 and Epac2 Agonists" (Link to PLoS Biology)